Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease

Sarah E Flanagan1, Emma Haapaniemi2,3, Mark A Russell1

  • 1Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, EX2 5DW, UK.

Nature Genetics
|July 21, 2014
PubMed

Insights

New research identifies de novo germline activating STAT3 mutations as a monogenic cause of early-onset autoimmune diseases, including type 1 diabetes. This contrasts with inactivating mutations linked to hyper IgE syndrome, highlighting STAT3

Area of Science:

  • Immunology
  • Genetics
  • Endocrinology

Background:

  • Monogenic causes of autoimmunity offer critical insights into immune system regulation.
  • Signal transducer and activator of transcription 3 (STAT3) is crucial in immune responses.

Purpose of the Study:

  • To identify novel monogenic causes of autoimmunity.
  • To investigate the role of STAT3 in early-onset autoimmune diseases.

Main Methods:

  • Genetic analysis of five individuals with early-onset autoimmune disease.
  • Characterization of de novo germline STAT3 mutations.

Main Results:

  • Identified activating STAT3 mutations as a new monogenic cause of autoimmunity.
  • Observed a spectrum of early-onset autoimmune conditions, including type 1 diabetes.
  • Demonstrated that activating STAT3 mutations lead to autoimmune disease, contrasting with inactivating mutations causing hyper IgE syndrome.

Conclusions:

  • Activating STAT3 mutations represent a novel monogenic cause of early-onset autoimmune disease.
  • STAT3 plays a critical and dual role in autoimmune pathogenesis.
  • Findings expand understanding of immune dysregulation in monogenic autoimmune disorders.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K